PMID- 20655153
OWN - NLM
STAT- MEDLINE
DCOM- 20101230
LR  - 20181201
IS  - 2214-8116 (Electronic)
IS  - 0398-0499 (Linking)
VI  - 35
IP  - 4
DP  - 2010 Jul
TI  - [Perioperative use of antithrombotic agents: recommendations of the American 
      College of Chest Physicians (ACCP) and the French Superior Health Authority 
      (HAS)].
PG  - 220-34
LID - 10.1016/j.jmv.2010.05.005 [doi]
AB  - The purpose of this work was to analyse management practices for patients given 
      anticoagulants or antiplatelet agents such as aspirin, clopidogrel and who are to 
      undergo an invasive procedure or surgery. The modalities for the transition from 
      oral agents to low-molecular-weight-heparin (LMWH) or unfractionated heparin 
      (UFH) are studied. The recommendations or suggestions using the ACCP score: grade 
      1 recommendations are strongly motivated and indicate whether the benefit 
      overbalances or not the risk, the burden, and the cost of the treatment. Grade 2 
      recommendations are considered to be suggestions. They imply that the individual 
      physician chooses between different therapeutic strategies. For the purpose of 
      this work, the most important recommendations are the following:
CI  - Copyright 2010. Published by Elsevier Masson SAS.
FAU - Samama, M M
AU  - Samama MM
AD  - Groupe interdisciplinaire Trousseau sur les antithrombotiques, unite 
      hemostase-thrombose, Hotel-Dieu, Parvis Notre-Dame, 75181 Paris cedex 04, France. 
      MeyerMichel.SAMAMA@biomnis.com
FAU - Horellou, M H
AU  - Horellou MH
FAU - Achkar, A
AU  - Achkar A
FAU - Conard, J
AU  - Conard J
CN  - collaboration de F Mauriat
LA  - fre
PT  - Journal Article
TT  - La prise en charge perioperatoire des traitements antithrombotiques. Des 
      recommandations de l'American College of Chest Physicians (ACCP) a celles de la 
      Haute Autorite de sante (HAS).
DEP - 20100723
PL  - France
TA  - J Mal Vasc
JT  - Journal des maladies vasculaires
JID - 7707965
RN  - 0 (Anticoagulants)
RN  - 0 (Fibrinolytic Agents)
RN  - 0 (Heparin, Low-Molecular-Weight)
RN  - 0 (Platelet Aggregation Inhibitors)
RN  - 9005-49-6 (Heparin)
RN  - A74586SNO7 (Clopidogrel)
RN  - OM90ZUW7M1 (Ticlopidine)
SB  - IM
MH  - Anticoagulants/therapeutic use
MH  - Atrial Fibrillation/complications
MH  - Cardiac Surgical Procedures/*methods
MH  - Clopidogrel
MH  - Fibrinolytic Agents/*therapeutic use
MH  - France
MH  - Heart Valve Prosthesis Implantation/adverse effects
MH  - Heparin/therapeutic use
MH  - Heparin, Low-Molecular-Weight/therapeutic use
MH  - Humans
MH  - Platelet Aggregation Inhibitors/therapeutic use
MH  - Risk Factors
MH  - Societies, Medical
MH  - Ticlopidine/analogs & derivatives/therapeutic use
MH  - United States
EDAT- 2010/07/27 06:00
MHDA- 2010/12/31 06:00
CRDT- 2010/07/27 06:00
PHST- 2010/03/22 00:00 [received]
PHST- 2010/05/04 00:00 [accepted]
PHST- 2010/07/27 06:00 [entrez]
PHST- 2010/07/27 06:00 [pubmed]
PHST- 2010/12/31 06:00 [medline]
AID - S0398-0499(10)00167-8 [pii]
AID - 10.1016/j.jmv.2010.05.005 [doi]
PST - ppublish
SO  - J Mal Vasc. 2010 Jul;35(4):220-34. doi: 10.1016/j.jmv.2010.05.005. Epub 2010 Jul 
      23.